To assess posterior fossa brain arteriovenous malformation (PFbAVM) patients who received initial endovascular intervention to reduce the lesion size, as well as embolization for the obliteration of the lesions.
█ INTRODUCTION
P osterior fossa brain arteriovenous malformations (PFbAVM) comprise 5-18% of brain arteriovenous malformations (AVMs). However, PFbAVMs carry a nearly 2-fold greater risk of hemorrhage, compared with other supratentorial equivalents (2,7). Feeding artery aneurysms, deep venous drainage, small lesion size, and age constitute predictive factors for hemorrhage (11) . PFbAVMs can be classified by region to organize treatment planning. Lesions may be present on cerebellum (vermis, hemisphere, or combined), brainstem (medulla, pons, or midbrain), or a combination of these 2 regions (3). Presentation differs between supratentorial and infratentorial AVMs. Unlike supratentorial bAVMs, PFbAVMs typically exhibit no symptoms; therefore, they are often diagnosed after hemorrhage occurs, which leads to persistent and severe neurologic findings (10) . Reportedly, 72%-92% of patients had at least 1 previous bleeding episode (2,8). Observation, endovascular interventions, surgical resection, radiosurgery, or combinations of these modalities constitute the available treatment options. Most cerebellar AVMs are suitable for microsurgery in which obliteration rates are high (70%-100%). Brainstem AVMs are more complicated because of their high mortality and morbidity rates. Therefore, treatment choices for brainstem AVMs are often endovascular techniques and/or radiosurgery (6) . The goal of treatment is complete obliteration. Some characteristics, such as eloquent location (e.g., cranial nerves, brainstem structures, or cerebral arteries) and high Spetzler-Martin (SM) grade, hinder total excision via microsurgery. Additionally, complete excision of PFbAVM, particularly those contiguous to important structures, can enhance mortality and morbidity. Notably, improvement of endovascular intervention techniques and embolization materials has made endovascular embolization a better choice for PFbAVM treatment. Endovascular embolization can be used as an adjuvant treatment to lower the volume of the nidus before microsurgery or stereotactic radiosurgery; this approach may reduce mortality and morbidity (1). There remains debate regarding the influence of patient age, sex, clinical presentation, lesion location, venous drainage pattern, AVM size, and whether feeding artery-associated aneurysms are involved. We reviewed demographic findings, clinical findings, imaging results, and outcomes of patients with PFbAVM treated between 2010 and 2017 in order to determine the factors associated with treatment modalities, as well as to evaluate the proficiency of endovascular embolization as adjuvant or final treatment.
█ MATERIAL and METHODS
Our study was confirmed by the institutional supervision committee and all patients granted informed consent. Sex, clinical presentation, age, lesion location (eloquent or noneloquent), PFbAVM size, deep venous drainage (presence or absence), SM grade, feeding artery aneurysms, treatment modalities, complications, and outcomes were reviewed for all patients. Patients were categorized on the basis of the presence of hemorrhage, according to their clinical presentation. Lesion locations were categorized as eloquent (e.g., major motor pathways, cranial nerves, cerebellum, brainstem, deep cerebellar nuclei, or peduncles) or noneloquent. Venous drainage of PFbAVMs was categorized as deep or superficial (6) . The PFbAVM size was classified into 3 groups according to maximum nidus diameter: <3 cm, 3-6 cm, or >6 cm. All patients' PFbAVMs were also graded according to the SM grading scale: I to V (11, 13) (Table I) . Finally, all patients were divided according to the presence of a feeding artery aneurysm, which comprises a sac formed by localized dilatation with a diameter at least 2-fold that of the primary vessel. The mean follow-up period from diagnosis to the final follow-up was 2.3 years.
When determining the treatment modality, considering that demographic risks and concomitant diseases were factors that attenuated the treatment effect, the following aspects were assessed: sex, presentation with hemorrhage or hydrocephalus, age, SM grade, presentation modified Rankin Scale (mRS) score, the presence of deep venous drainage, angiographic features, and lesion location.
Sixteen patients received multimodal treatment, including any combination of surgery and embolization. Microsurgery was performed in patients with hemorrhages because of the risk of compression of the brainstem or fourth ventricle, which can cause hydrocephalus or cerebral hernia. By reduction of bleeding, embolization was performed before microsurgery, with the aim of facilitating the operation, reducing complications, and providing complete elimination of the PFbAVM. For unruptured small PFbAVMs (<3 cm) with superficial or non-eloquent locations, particularly in young patients, microsurgery was performed to prevent future hemorrhages. The overall goal was complete elimination of the lesion. If total elimination was not possible by one modality alone, multi-modality treatment was considered. Multistage endovascular treatment was appropriate for large PFbAVMs, higher SM grades, and deep locations. Adjuvant endovascular treatment was used before surgery or radiosurgery to lower the risk of persistent neurological impairments. All patients received endovascular treatment as adjuvant therapy (n=7) or multistage embolization as final treatment (n=9). Patients who were referred to an external radiosurgery center because of the absence of the radiosurgery department at our hospital were excluded from the study.
As an index for outcome evaluation, the mRS was used; mRS results were categorized as good outcome (MRS≤2) or poor outcome (MRS≥3).
Endovascular Embolization Procedures
Entire endovascular embolization treatments were applied via transfemoral arterial entry at the same hospital's treatment center by one interventional neuroradiologist and one neurosurgeon with a long-term expertise in endovascular embolization. General anesthesia was administered to the patients and a local antiseptic agent was used for sterilization of the groin. Using a micropuncture set from the right femoral artery, the Neuron (Penumbra, Alameda, CA, USA) guiding sheath was placed with the aid of 80 cm SIM 2 125 (Cook Medical, Bloomington, IN, USA). The feeding artery supplying the lesion was superselected using an Apollo microcatheter (Medtronic, Minnesota, MN, USA), Excelsior SL10 microcatheter (Stryker, San Jose, CA, USA), or Mirage micro guidewire (ev3, Irvine, CA, USA). First, to avoid thrombogenesis, systemic heparinization was applied. Continuous saline injection was performed via microcatheter. Under real-time road mapping using digital subtraction angiography (DSA), a 5% glucose solution was infused from the microcatheter. Coils, stents, and stent-assisted coils were used for embolization. There was no residual aneurysmatic filling on the control angiograms. Right femoral puncture point was closed with 6F Angioseal (Terumo, Somerset, NJ, USA) after right femoral artery catheter extraction. Patients with normal vital signs were extubated. Post-operative care was completed in the intensive care unit. For 48-72 hours, patient blood pressure was maintained at 20 or 30 mmHg lower than normal values. A computerized tomography (CT) scan was performed to detect bleeding or other complications.
Statistical Analysis
Percentages and frequencies were calculated for categorical variables. Standard deviations (SD) and the mean were calculated for continuous variables. Categorical 
RESULTS
In this study, 16 posterior fossa AVM patients were diagnosed and treated via surgery between 2010 and 2017 (mean age 37.06 years, range 11-66 years); 7 (43.75%) exhibited hemorrhage, 16 (100%) exhibited headache (including all hemorrhagic patients) and 2 (12.5%) exhibited focal neurological deficits. The clinical findings, demographic variables, outcome indexes, and angiographic characteristics of AVMs are summarized in Table I. A total of 21 endovascular embolization procedures were performed. Nine (56.25%) patients achieved complete obliteration. Complete obliterations of all lesions were confirmed by DSA after the first and fourth months after endovascular embolization procedures ( Figure 1A-G) . Seven patients had residual nidus that was treated with microsurgery (n = 7) as an additional modality. The duration of follow-up was performed for mean 2.3 years (range 1.1-4.6 years).
Transient complications related to treatment were found in 2 (12.5%) patients: one was due to embolization-induced transient ischemia, the other was due to subarachnoid hemorrhage-induced vasospasm.
Compared with patients treated with endovascular embolization, those treated with surgery or surgery-endovascular embolization combination treatment did not have a better chance of excellent outcome (mRS ≤ 2) on multivariate analysis. The PFbAVM location, size, and clinical grade did not significantly No significant differences were found in sex ratio, age, related feeding artery aneurysms, number of cases with PFbAVM size less than 3 cm, and low SM grade (grade I and II) between the patient groups with and without hemorrhage. Cerebellar position (p=0.008) and deep venous drainage (p=0.037) were independent predictors of hemorrhage in multivariate analysis.
The demographic and angiomorphologic characteristics of all PFbAVM patients are summarized in Table I . Six (37.5%) patients had PFbAVM in the cerebellum, 2 (12.5%) patients had PFbAVMs in the brainstem, and in the remaining patients (n=8, 50%), lesions were combined. Fifteen (93.75%) lesions were ≥3 cm and 1 (6.25%) lesion was <3 cm. Eleven patients (68.75%) were of SM grade ≥ III; the remaining 5 (31.25%) patients were SM grade ≤ II. Ten (62.5%) of the patients had deep venous drainage; 6 (37.5%) had superficial venous drainage. When patient outcomes and mortality-morbidity rates were compared, there were no statistically significant differences between patients treated with final endovascular treatment and those treated with a combination of surgical and endovascular treatment modalities. In our study, embolization was used both as an adjuvant treatment option and as a final treatment. Multistage endovascular treatment was appropriate for lesions with higher SM grades, large lesions, and those in deep locations. There were no statistically significant differences in mortality and morbidity on the basis of the type of surgery. In 9 patients, multistage embolization was used as the last treatment and complete obliteration was achieved. The other 7 patients showed residual nidus during control DSA; therefore, they underwent surgery as further treatment. Complete obliteration was achieved in all of these patients.
This study has similar limitations to those of other retrospective studies. Our hospital is a tertiary medical center; therefore, this study may include patients whose risk and management is more difficult than typically encountered, which may be a bias in the treatment of patients. In addition, patient sample size and follow-up time led to insufficient statistical outcomes regarding the natural history of the PFbAVMs.
█ CONCLUSION
Considering today's evolving embolization techniques and increasing experience, embolization will likely become superior to surgery in lesions with high mortality and morbidity, such as PFbAVMs. (16) .
Patients that presented with hemorrhage showed greater neurological deficit, both before and after surgery (6) . Increased bleeding of cerebellar AVMs is not clearly understood (9, 14) . Furthermore, patients presenting with PFbAVM bleeding have a remarkable re-hemorrhage rate (8.4%-9.4% per year) (8) . These patients also exhibit increased morbidity and mortality rates after re-hemorrhage. Consequently, such patients require more aggressive treatment, as long as the treatment risks are at acceptable levels.
The size of the nidus is associated with an increased risk of rupture. A small nidus has a higher risk of rupture; however, there is no difference in size between cerebellar AVMs and cerebral AVMs. Importantly, cerebellar AVM patients with feeding artery aneurysms had a similar incidence of hemorrhage (9) . A notable difference between cerebellar and cerebral AVMs is that patients with cerebral AVMs may present with seizures. Finally, PFbAVM-associated seizures or other apparent symptoms are rare; thus, diagnosis of PFbAVMs is difficult without hemorrhage, and late diagnosis of these lesions contributes to an increased incidence of hemorrhage (10, 15) .
Complete obliteration is the gold standard for high-risk PFbAVM treatment (11) . Microsurgery is considered the best modality for high-risk lesions because of its high obliteration rate; however, the limited and complex surgical area is associated with high mortality and morbidity, due to its proximity to important centers and vascular structures (6% and 16%, respectively) (1,12). 
